Sangamo begins $100M shelf offering

Sangamo BioSciences (SGMO) offers $100M of common stock for public sale.

Proceeds to be used for working capital and general corporate purposes.

Prospectus supplement filed today as a follow-on to its S-3 filed on February 25.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs